30 Day Trial

NuVasive Posts 4Q17, 2017 Revenue

Share:

NuVasive reported 4Q17 revenue of US $271.7MM, +0.2% vs. 4Q16, and 2017 revenue of $1,029.5MM, +7.0% vs. 2016.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.